It is worth noting that an increase in CD271+ MSPCs in the BM in MDS and AML versus normal/reactive BM has been described, with the increase being more pronounced and statistically significant in low-risk MDS compared to high-risk MDS or AML. The gene discussed is NGFR; the disease is myelodysplastic syndrome.